
WHEN a crayfish sheds its protective exoskeleton, it becomes temporarily vulnerable to attack by predators. Now there is evidence that this leads to behaviour that resembles anxiety, and that this can be relieved using the same anti-anxiety drugs that humans take.
“They worry, they have an apprehension state that makes them avoid potentially dangerous areas. It’s kind of like a primitive anxiety,” says Pascal Fossat at the University of Bordeaux in France.
Fossat and his colleagues collected crayfish from swamps near Bordeaux and stored them in individual tanks that mimicked their natural habitat.
Advertisement
When the crayfish began to moult, the researchers placed them in a maze that had two dark sections and two lit sections, and recorded their behaviour.
Over the following two days, the crayfish showed a strong preference for hiding in the dark regions. If they did encounter the lit sections, they retreated into the dark in 80 per cent of cases.
For comparison, when the crayfish weren’t moulting they typically spent about 30 per cent of their time in the light.
“They’re very weak when they remove the old exoskeleton, and the new one is totally soft until they eat the old one to get back the minerals that make the new exoskeleton stronger,” says Fossat. “They’re vulnerable, so they have to hide.”
The team also took crayfish that weren’t moulting and injected them with an ecdysteroid – a class of hormone that controls moulting, produced by many animals with an exoskeleton. They found that the crayfish exhibited the same anxiety-like behaviour, avoiding light and retreating to the dark.
To explore whether it was possible to suppress this behaviour, Fossat and his colleagues took the animals they had treated with the ecdysteroid and injected them with anti-anxiety drugs developed for use in humans. The crayfish returned to spending about one-third of their time in the light.
“They didn’t have the apprehension from before,” says Fossat ().
Robert Elwood at Queen’s University Belfast in the UK says it is surprising that anti-anxiety drugs designed for human use also work on invertebrates, given that they last shared a common ancestor with us hundreds of millions of years ago. “I was taken aback [by] that,” he says.
Fossat suspects crayfish may be capable of other primitive emotions – although it is a difficult subject to investigate because crayfish are biologically so different from humans.
Elwood says the animals may be acting on basic physiological mechanisms that humans have interpreted as feelings. But he says that new research is helping us understand the range of emotions invertebrates may experience.
“We’ve spent a lot of time worried about animal welfare, asking whether they are in stress or pain,” he says. “Now we’re beginning to turn that over and ask if we can say when an animal is happy or gleeful.”